Fennec Pharmaceuticals, Inc. (FENC)
12.76
+1.14
(+9.81%)
USD |
NASDAQ |
Nov 16, 16:00
12.58
-0.18
(-1.41%)
After-Hours: 20:00
Fennec Pharmaceuticals Price : 12.76 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 11.92 | 12.88 | 11.77 | 12.76 | 793198.0 |
| Nov 13, 2026 | 11.12 | 12.12 | 10.92 | 11.62 | 461310.0 |
| Nov 12, 2026 | 10.72 | 11.64 | 10.26 | 10.90 | 284814.0 |
| Nov 11, 2026 | 10.78 | 10.80 | 10.45 | 10.64 | 268815.0 |
| Nov 10, 2026 | 10.68 | 10.95 | 10.27 | 10.58 | 228388.0 |
| Nov 09, 2026 | 9.95 | 11.00 | 9.88 | 10.83 | 245801.0 |
| Nov 06, 2026 | 9.42 | 10.06 | 9.20 | 9.81 | 134013.0 |
| Nov 05, 2026 | 10.42 | 10.62 | 9.33 | 9.39 | 161804.0 |
| Nov 04, 2026 | 10.99 | 11.09 | 10.25 | 10.35 | 160720.0 |
| Nov 03, 2026 | 10.63 | 10.83 | 10.22 | 10.70 | 135036.0 |
| Nov 02, 2026 | 10.37 | 10.60 | 10.01 | 10.54 | 182900.0 |
| Oct 30, 2026 | 10.89 | 11.05 | 10.14 | 10.24 | 195651.0 |
| Oct 29, 2026 | 10.96 | 11.25 | 10.70 | 10.95 | 180560.0 |
| Oct 28, 2026 | 10.62 | 10.89 | 10.39 | 10.87 | 149546.0 |
| Oct 27, 2026 | 10.18 | 10.64 | 10.05 | 10.62 | 93186.00 |
| Oct 26, 2026 | 10.08 | 10.27 | 9.98 | 10.15 | 115942.0 |
| Oct 23, 2026 | 10.23 | 10.48 | 9.93 | 10.08 | 70821.00 |
| Oct 22, 2026 | 10.33 | 10.51 | 10.12 | 10.32 | 104170.0 |
| Oct 21, 2026 | 10.49 | 10.86 | 10.28 | 10.38 | 84493.00 |
| Oct 20, 2026 | 10.12 | 10.73 | 10.12 | 10.46 | 70989.00 |
| Oct 19, 2026 | 10.09 | 10.34 | 9.87 | 10.27 | 103553.0 |
| Oct 16, 2026 | 10.20 | 10.35 | 9.87 | 9.98 | 129972.0 |
| Oct 15, 2026 | 9.98 | 10.47 | 9.88 | 10.35 | 112304.0 |
| Oct 14, 2026 | 10.10 | 10.31 | 9.92 | 9.98 | 207584.0 |
| Oct 13, 2026 | 10.72 | 10.75 | 10.08 | 10.18 | 231642.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.67 |
| Alnylam Pharmaceuticals, Inc. | 159.73 |
| Anika Therapeutics, Inc. | 12.92 |
| Savara, Inc. | 4.465 |
| Arrowhead Pharmaceuticals, Inc. | 44.21 |
Price Related Metrics
| PE Ratio | 764.07 |
| PS Ratio | 6.788 |
| Price to Book Value | 9.135 |
| Price to Free Cash Flow | 383.13 |
| Earnings Yield | 0.13% |
| Market Cap | 449.34M |
| Operating PE Ratio | 138.37 |
| Normalized PE Ratio | 205.48 |